Baclofen in the treatment of trigeminal neuralgia: Double‐blind study and long‐term follow‐up
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
A double‐blind crossover study of the effects of baclofen was conducted on 10 patients with typical trigeminal neuralgia. Baclofen significantly decreased the number of painful paroxysms in 7 of the 10 patients. An open trial in another 50 patients with trigeminal neuralgia refractory to or unable to tolerate carbamazepine showed that 37 (74%) were relieved of their attacks by baclofen, either alone (12 patients) or in combination with previously ineffective doses of carbamazepine or phenytoin (25). On long‐term follow‐up of one to five years (mean, 3.0 years), 18 of the 60 patients (30%) continued pain free while receiving baclofen; 10 (17%) went into remission after 3 to 6 months; 13 (22%) became refractory to baclofen after 1 to 18 months; and 2 (3%) elected operation despite a good response to baclofen. The results indicate that baclofen is a useful drug in the treatment of trigeminal neuralgia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism and Management of Headache
(2005) · Elsevier eBooks · doi:10.1016/b978-0-7506-7530-7.x5001-4 · Cited by 406
Carbamazepine in the Treatment of Neuralgia: Use and Side Effects
Killian, J. M. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00480020015001 · Cited by 329
Long-term treatment of trigeminal neuralgia with carbamazepine
Taylor, J. C., Brauer, S., & Espir, M. L. E. (1981) · Postgraduate Medical Journal · doi:10.1136/pgmj.57.663.16 · Cited by 258
DAVIES, J. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb09137.x · Cited by 246
Action of baclofen on mammalian synaptic transmission
Fox, S., Krnjević, K., Morris, M. E., Puil, E., & Werman, R. (1978) · Neuroscience · doi:10.1016/0306-4522(78)90016-7 · Cited by 199
BACLOFEN: EFFECTS ON AMINO ACID RELEASE AND METABOLISM IN SLICES OF GUINEA PIG CEREBRAL CORTEX
Potashner, S. J. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb04516.x · Cited by 182
McLeod, J. G. (1974) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb71026.x · Cited by 172
Controlled Sequential Trials of Carbamazepine in Trigeminal Neuralgia
ROCKLIFF, B. W., & DAVIS, E. H. (1966) · Archives of Neurology · doi:10.1001/archneur.1966.00470140019003 · Cited by 169
Complications of Baclofen Withdrawal
Terrence, C. F., & Fromm, G. H. (1981) · Archives of Neurology · doi:10.1001/archneur.1981.00510090082011 · Cited by 123
Self-citationThe blocking action of baclofen on excitatory transmission in the rat hippocampal slice
Olpe, H. ‐., Baudry, M., Fagni, L., & LYNCH, G. S. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-06-00698.1982 · Cited by 87
Cited by
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
AAN-EFNS guidelines on trigeminal neuralgia management
Cruccu, G., Gronseth, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02185.x · Cited by 726
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 713
Gronseth, G., Cruccu, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000326598.83183.04 · Cited by 607
Neuropathic pain: a practical guide for the clinician
Gilron, I. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060146 · Cited by 450
Systematic review of outpatient services for chronic pain control.
McQuay, Moore, Eccleston, Morley, & Williams (1997) · Health Technology Assessment · doi:10.3310/hta1060 · Cited by 424
Trigeminal neuralgia—pathophysiology, diagnosis and current treatment
Nurmikko, T. J., & Eldridge, P. R. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.1.117 · Cited by 417
Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub2 · Cited by 392
RetractedTrigeminal neuralgia: An overview from pathophysiology to pharmacological treatments
Gambeta, E., Chichorro, J. G., & Zamponi, G. W. (2020) · Molecular Pain · doi:10.1177/1744806920901890 · Cited by 376
Chu, D. C. M., Albin, R. L., Young, A. B., & Penney, J. B. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90144-s · Cited by 351
Combination pharmacotherapy for the treatment of neuropathic pain in adults
Chaparro, L. E., Wiffen, P. J., Moore, R. A., & Gilron, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008943.pub2 · Cited by 310
Orofacial pain management: current perspectives
Romero-Reyes, M., & Uyanik, J. M. (2014) · Journal of Pain Research · doi:10.2147/jpr.s37593 · Cited by 303
Trigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglion
Rappaport, H. Z., & Devor, M. (1994) · Pain · doi:10.1016/0304-3959(94)90086-8 · Cited by 303
Treatments for spasticity and pain in multiple sclerosis: a systematic review
Beard, S., Hunn, A., & Wight, J. (2003) · Health Technology Assessment · doi:10.3310/hta7400 · Cited by 266
(1988) · doi:10.1001/archneur.1989.00520450030015 · Cited by 173
Metadata
- Authors
- Fromm, G. H., Terrence, C. F., & Chattha, A. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1984-03
- Volume
- 15
- Issue
- 3
- Pages
- 240-244
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2025817423
- Cited by
- 368
- References
- 12
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.